Venous Thromboembolism in Hospitalized COVID-19 Patients : American Journal of
Therapeutics Venous Thromboembolism in Hospitalized COVID-19 Patients : American Journal …

Background: Coagulopathy associated with COVID-19 infection and venous
thromboembolism (VTE) have emerged as significant contributors to morbidity among …

Background There are few data on the incidence of thrombosis among COVID-19 cases,
with most research concentrated on hospitalised patients. We aimed to estimate the …

Background Venous thromboembolism (VTE) may complicate the course of Coronavirus
Disease 2019 (COVID-19). Objectives To evaluate the incidence of VTE in patients with …

Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …

Introduction Venous thromboembolism (VTE) has been observed as a frequent complication
in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring …

Background COVID-19 may predispose to both venous and arterial thromboembolism event
(TEE). Reports on the prevalence and prognosis of thrombotic complications are still …

Data regarding the occurrence of venous thromboembolic events (VTE), including acute
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …

Abstract Coronavirus disease (COVID-19) is caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and is responsible for the ongoing 2019–2020 …

Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …